Analysis of cyclic and acyclic nicotinic cholinergic agonists using radioligand binding, single channel recording, and nuclear magnetic resonance spectroscopy.
The relationship between the structure and function of a series of nicotinic cholinergic agonists has been studied using radioligand binding, single channel recording, and nuclear magnetic resonance spectroscopy. The cyclic compound 1,1-dimethyl-4-acetylpiperazinium iodide and its trifluoromethyl analogue (F3-PIP) interact with nicotinic acetylcholine receptors (nAChRs) from both Torpedo electroplaque and BC3H-1 cells at lower concentrations than the acyclic derivatives, N,N,N,N'-tetramethyl-N'-acetylethylenediamine iodide and its fluorinated analogue (F3-TED). The magnitude of the difference in potencies depends on the type of measurement. In binding experiments, the differences between the two classes of compounds depends mainly on the conditions of the experiment. In measurements of the initial interaction with the nAChR, the PIP compounds have an affinity approximately one order of magnitude higher than that of the TED compounds. Longer incubations indicated that the PIP compounds were able to induce a time-dependent shift in receptor affinity consistent with desensitization, whereas the TED compounds were unable to induce such a shift. The activation of single channel currents by the cyclic compounds occurs at concentrations approximately two orders of magnitude lower than for the acyclic compounds, but the TED compounds exhibit a larger degree of channel blockade than the PIP compounds. Previous work (McGroddy, K.A., and R.E. Oswald. 1992. Biophys. J. 64:314-324) has shown that the TED compounds can exist in two energetically distinct conformational states related by an isomerization of the amide bond. 19F nuclear magnetic resonance experiments suggest that the higher energy population of the TED compounds may interact preferentially with the ACh binding sites on the nAChRs and that a significant fraction of the difference between the initial affinity of the PIP and TED compounds may be accounted for by the predominance in solution of a conformational state less able to interact with the ACh binding sites on nAChRs.
McGroddy
K A
KA
Department of Pharmacology, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853.
Carter
A A
AA
Tubbert
M M
MM
Oswald
R E
RE
D000818:Animals; D001665:Binding Sites; D055592:Biophysical Phenomena; D001703:Biophysics; D004563:Electrochemistry; D005029:Ethylenediamines / Q000737:chemistry; D066298:In Vitro Techniques; D007700:Kinetics; D009682:Magnetic Resonance Spectroscopy; D010277:Parasympathomimetics / Q000737:chemistry*; D010879:Piperazines / Q000737:chemistry; D000644:Quaternary Ammonium Compounds / Q000737:chemistry; D011869:Radioligand Assay; D011978:Receptors, Nicotinic / Q000737:chemistry; D013816:Thermodynamics; D014101:Torpedo
D005029:Ethylenediamines; D010277:Parasympathomimetics; D010879:Piperazines; D000644:Quaternary Ammonium Compounds; D011978:Receptors, Nicotinic; C080420:N,N,N,N'-tetramethyl-N'-acetylethylenediamine; C080419:1,1-dimethyl-4-acetylpiperazinium